New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
04:55 EDTA, A, A, A, RHHBY, RHHBY, RHHBY, RHHBY, PKI, PKI, PKI, PKI, LIFE, LIFE, LIFE, LIFE, ILMN, ILMN, ILMN, ILMN, QGEN, QGEN, QGEN, QGEN, PACB, PACB, PACB, PACBG Corp to host a meeting
14th Annual Advances in Genome Biology and Technology Meeting is being held on Marco Island, Florida on February 20-23.
News For A;RHHBY;PKI;LIFE;ILMN;QGEN;PACB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 30, 2014
08:18 EDTAAgilent risk/reward favorable into spin-off, says Leerink
Subscribe for More Information
08:18 EDTAAgilent risk/reward favorable into spin-off, says Leerink
Subscribe for More Information
07:30 EDTRHHBY, QGENSachs Associates to hold a conference
14th Annual Biotech in Europe Forum for Global Partnering and Investment to be held in Basel, Switzerland on September 30-October 1.
September 29, 2014
16:20 EDTAAgilent says regulatory authorities close past FCPA probe
Agilent disclosed in a filing that on September 6, 2013, Agilent Technologies disclosed in its Form 10-Q that it had initiated an internal investigation relating to certain sales of company products through third party intermediaries in China and compliance by company employees in China with the requirements of the U.S. Foreign Corrupt Practices Act and other applicable laws and regulations. The company further disclosed that it had voluntarily advised the United States Department of Justice and the United States Securities and Exchange Commission of the investigation. On September 15, the company received a letter from the SECís Division of Enforcement stating that its investigation had been completed and that the Division of Enforcement did not intend to recommend any enforcement action against the company by the SEC. On September 24, the company received a letter from DOJ stating that DOJ had closed its inquiry into the matter, citing the companyís voluntary disclosure and thorough investigation.
11:02 EDTAAgilent announces collaboration with University of Toronto
Agilent announced a collaboration with scientists at the University of Torontoís Donnelly Centre for Cellular and Biomolecular Research to produce a comprehensive metabolomics multiple-reaction monitoring library and methodology, using Agilentís Infinity 1290 UHPLC and 6460 triple quadrupole mass spectrometry system.
08:11 EDTRHHBYRoche sees completing InterMune acquisition later today
Subscribe for More Information
05:35 EDTRHHBYExelixis announces positive results from Phase 3 pivotal trial of cobimetinib
Subscribe for More Information
September 28, 2014
12:49 EDTRHHBYRoche announces final survival results from Phase III CLEOPATRA study
Subscribe for More Information
September 26, 2014
07:22 EDTAAgilent management to meet with Jefferies
Meeting to be held in the Mid-Atlantic area on October 2 hosted by Jefferies.
September 24, 2014
10:58 EDTRHHBYRoche to host conference call
Conference call to discuss new clinical data on Roche's oncology products and pipeline that were presented at the European Society for Medical Oncology's Annual Meeting will be held on September 29 at 4 am. Webcast Link
September 22, 2014
19:23 EDTRHHBYRoche management to meet with JPMorgan
Subscribe for More Information
13:53 EDTRHHBYRoche launches $5.75B bond to back InterMune acquisition, Reuters reports
Subscribe for More Information
08:38 EDTQGENQIAGEN to begin new buyback program after completing prior one
QIAGEN informed that it will commence the launch of a share repurchase program after completing its prior program on September 17. Reference Link
September 20, 2014
15:43 EDTRHHBYInterMune reports MOU in connection with consolidated Delaware action
Subscribe for More Information
September 17, 2014
18:29 EDTAOn The Fly: After Hours Movers
Subscribe for More Information
17:01 EDTAAgilent board approves separation of Keysight, declares special dividend
Subscribe for More Information
16:57 EDTAAgilent creates new group for services, consumables
Subscribe for More Information
16:55 EDTAAgilent announces Mike McMullen to succeed Bill Sullivan as CEO in March 2015
Subscribe for More Information
11:00 EDTRHHBYRoche CEO rules out megadeals, focused on bolt-on acquisitions, WSJ says
Roche CEO Severin Schwan said the company won't change its acquisition strategy following the recent deals made or abandoned in the pharmaceutical sector, reports the Wall Street Journal. In an interview with WSJ, Shwan said, "We have been very consistent in our approach to M&A." Regarding transformational deal-making, he said, "We have no intention to do that, whatever happens in the industry." Reference Link
07:43 EDTRHHBYBofA/Merrill to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use